PharmaBoardroom’s new InFocus section examines the fast-growing and lucrative global medical cannabis market, touching on investment opportunities,…

Dr Tares Krassanairawiwong, secretary-general of the Thai FDA shares the recent reforms carried out in the hope of facilitating greater patient access…

GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019, demonstrating that cannabinoid-based…

Dentons Germany's Peter Homberg outlines the key requirements that companies need to fulfil in order to import medical cannabis into Germany and how…

Thailand has recently gained a new status as the first Asian country to legalise medical cannabis for medical treatment and research. In a sweeping…

Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries. Increasing Acceptance The…

A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…

David Bearman makes the historical case to be once again considered as a medicine across the USA, noting that economic – rather than health –…

Monica Weldon looks at the history of medicinal CBD, its current usages in the USA, and why robust scientific research on its efficacy need to be…

David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past year in investments in…

In the light of several recent regulatory updates to Canada’s cannabis laws, lawyer Jean-Raphaël Champagne examines the potential for cannabis to…

Peter Homberg of Dentons Germany examines the regulatory status quo around the free sale of products containing cannabidiol (CBD) across Europe.…